Corticobasal Degeneration
What is Corticobasal Degeneration?
Overview
Corticobasal degeneration (CBD) is an extremely rare and progressive brain disorder that affects movement, speech, and thinking. It is caused by the gradual breakdown of brain cells in specific areas that control motor function and cognition.
CBD often presents with very asymmetric symptoms—meaning one side of the body is more affected than the other. Common features include:
- Rigidity (muscle stiffness)
- Apraxia (difficulty coordinating movements to perform tasks)
- Myoclonus (sudden muscle jerks)
- Dystonia (abnormal muscle postures)
- Rarely, alien limb syndrome, where a hand or arm seems to move or act on its own
Corticobasal degeneration is a different condition pathologically than Parkinson’s disease (PD). It is known as a tauopathy, meaning that the tau protein misfolds and causes disruption of neuron function, whereas in PD the abnormal protein is called alpha-synuclein.
CBD is typically accompanied by dementia, speech may be halting or hesitant and swallowing problems are common.
Unfortunately, CBD can progress more rapidly than typical (idiopathic) PD, and patients typically lose the ability to walk or care for themselves within a few years of the onset of symptoms.
Who is Affected?
CBD is most often diagnosed in people between the ages of 50 and 70, but it can occur earlier or later. It affects men and women equally and is not thought to run strongly in families. Because it is so rare, many patients are initially misdiagnosed with Parkinson’s disease, stroke, or other neurological conditions before receiving a confirmed diagnosis.
Corticobasal Degeneration Symptomsrn& Causes
Symptoms
CBD symptoms usually begin on one side of the body and gradually spread. They may include:
- Muscle stiffness or rigidity
- Tremors or jerky movements
- Trouble performing learned tasks (apraxia) despite normal strength
- Difficulty with speech (slurred, slow, or halting speech)
- Problems swallowing
- Loss of balance and frequent falls
- Memory loss or confusion
- Personality or behavior changes
- Alien limb movements (rare but distinctive)
Causes
CBD is caused by the abnormal buildup of tau protein in brain cells, which leads to cell death in regions controlling movement and thinking. The exact reason why tau misfolds in CBD is not fully understood. Most cases occur randomly (sporadically) without a clear genetic link.
When to See a Doctor
Prompt evaluation can help rule out other treatable conditions and connect you with supportive care early. Seek medical evaluation if you notice:
- Unexplained jerky movements or abnormal postures.
- New or worsening speech or swallowing problems.
- Persistent stiffness or clumsiness on one side of the body.
- Trouble performing everyday tasks despite normal strength.
- Cognitive decline or sudden changes in personality.
Corticobasal Degeneration Diagnosis
CBD diagnosis is primarily based on a detailed neurological exam and review of symptoms. Brain imaging such as MRI can rule out other causes, and functional scans like FDG-PET may reveal patterns of reduced brain metabolism characteristic of CBD.
Currently, there is no single definitive test for CBD during life. Research is underway on advanced imaging methods that detect tau protein directly, which may make diagnosis more accurate in the future.

Corticobasal Degeneration Treatmentrn& Outcomes
Treatment Options
Treatment is limited. Clinical trials are exploring drugs that target tau protein directly, but these are still in early stages. There is currently no cure for CBD, and available treatments focus on managing symptoms and maintaining quality of life. Options may include:
Physical Therapy
To maintain mobility and reduce stiffness.
Occupational Therapy
To improve function and adapt daily activities.
Speech Therapy
To assist with communication and swallowing.
Medications
Parkinson’s drugs may offer limited benefit; medications for memory loss or mood changes can be helpful in some cases.
Patient Outcomes
CBD is a progressive condition, and symptoms typically worsen over time. Most people require assistance with daily activities within 3–5 years of onset. While life expectancy varies, many patients live 6–8 years after diagnosis. Quality of life can be significantly improved through a combination of medical care, therapy, and strong social support.
Managing Corticobasal Degeneration
Living with CBD requires a multidisciplinary approach:
- Regular follow-up with a neurologist who specializes in movement disorders.
- Home safety adaptations to prevent falls.
- Caregiver support to reduce stress and burnout.
- Advance care planning to prepare for future needs.
Meet our Expert Specialists & Surgeons
Experience Compassionate, Expert Care
At Pacific Neuroscience Institute, our team provides comprehensive evaluation, personalized treatment plans, and access to leading-edge clinical trials for CBD.
Learn More About Corticobasal Degeneration
CBD is progressive and incurable, but symptom management and therapy can improve quality of life.
Most people live 6–8 years after diagnosis, though this varies.
Usually stiffness, clumsiness, or difficulty with coordinated movement on one side of the body.
No. While symptoms can resemble Parkinson’s disease, CBD has a different underlying cause.
Treatment is focused on symptom management, often with a combination of medications, therapy, and supportive care.
Complications such as infections, aspiration pneumonia, or severe mobility loss are common causes.
Pain is not a primary symptom but can occur due to stiffness, abnormal postures, or falls.
Typically over 3–8 years, with symptoms gradually worsening.
No known prevention exists.
Providing physical support, ensuring safety, managing symptoms with therapy and medication, and offering emotional support.
It can, often due to swallowing difficulties or reduced appetite.
Resources

Get Expert Care from Leading Specialists
If you or a loved one has symptoms of CBD, early evaluation by a movement disorders specialist is essential. Our experts at Pacific Neuroscience Institute can provide a thorough diagnosis, tailor a care plan, and connect you with the latest research opportunities.
Written and reviewed by:
The Pacific Neuroscience medical and editorial team
We are a highly specialized team of medical professionals with extensive neurological and cranial disorder knowledge, expertise and writing experience.
Last Updated: